Dr. Steven D. Wexner, MD

Dr. Wexner practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Wexner's NPI, 1497719173, was assigned on April 12, 2006. Dr. Wexner graduated from Weill Cornell Medicine in 1982. Dr. Wexner holds Florida license ME0052280.

Dr. Wexner's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Wexner's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Wexner is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Wexner to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wexner practices. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Wexner's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Wexner is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Wexner's licenses on file in 4 states: Florida, Minnesota, Ohio and New York.

Dmand AI lists colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Wexner treats.

CMS data shows 365 Medicare services from Dr. Wexner across 14 procedure codes in 2024, for 199 Medicare patients. Medicare paid $50,561 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 199 Medicare patients who saw Dr. Wexner in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wexner's median patient age at 60, with 50% women.

In 2024, Dr. Wexner wrote 39 Medicare Part D claims for 21 patients. 82% of them were for generic drugs. CMS names the drug for 23 of them, across 1 drug with 11 or more claims each, at $302 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Wexner for performance year 2024, reported through an alternative payment model (APM). Dr. Wexner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 738 papers to Dr. Wexner, published from 2001 to 2025. 2024 was the busiest year, with 50. The most frequent topics are Laparoscopy, Postoperative Complications and Rectal Neoplasms. Dr. Wexner has published most often in Dis Colon Rectum. Dr. Wexner's most frequent co-authors are Juan J. Nogueras, MD, Jonathan E. Efron, MD and Justin Dourado, MD.

Dmand AI links Dr. Wexner to 5 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Crohn Disease, Flatulence and Rectal Diseases. Open Payments lists research payments to Dr. Wexner that name 1 trial.

CMS Open Payments shows 317 general payments to Dr. Wexner from 26 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 46% of the total. Intuitive Surgical, Inc. paid the most, $652,986. It also lists 1 research payment totaling $2,400 in 2021, naming 1 clinical trial.

Dmand AI lists 98 awards for Dr. Wexner, most recently Honorary Fellow in 2022.

Dr. Wexner graduated from Weill Cornell Medicine in 1982. Dr. Wexner is a member of ACG, ACS, ASGE, ASCRS, American Surgical Association and SAGES.

Dr. Wexner is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.